Stepwise Stiffening/Softening of and Cell Recovery from Reversibly Formulated Hydrogel Double Networks.
Irina KopyevaEthan C GoldnerJack W HoyeShiyu YangMary C RegierKaitlyn R VeraRoss C BrethertonCole A DeForestPublished in: bioRxiv : the preprint server for biology (2024)
Biomechanical contributions of the ECM underpin cell growth and proliferation, differentiation, signal transduction, and other fate decisions. As such, biomaterials whose mechanics can be spatiotemporally altered - particularly in a reversible manner - are extremely valuable for studying these mechanobiological phenomena. Herein, we introduce a poly(ethylene glycol) (PEG)-based hydrogel model consisting of two interpenetrating step-growth networks that are independently formed via largely orthogonal bioorthogonal chemistries and sequentially degraded with distinct bacterial transpeptidases, affording reversibly tunable stiffness ranges that span healthy and diseased soft tissues (e.g., 500 Pa - 6 kPa) alongside terminal cell recovery for pooled and/or single-cell analysis in a near "biologically invisible" manner. Spatiotemporal control of gelation within the primary supporting network was achieved via mask-based and two-photon lithography; these stiffened patterned regions could be subsequently returned to the original soft state following sortase-based secondary network degradation. Using this approach, we investigated the effects of 4D-triggered network mechanical changes on human mesenchymal stem cell (hMSC) morphology and Hippo signaling, as well as Caco-2 colorectal cancer cell mechanomemory at the global transcriptome level via RNAseq. We expect this platform to be of broad utility for studying and directing mechanobiological phenomena, patterned cell fate, as well as disease resolution in softer matrices.
Keyphrases
- single cell
- rna seq
- drug delivery
- high throughput
- cell fate
- cell therapy
- gene expression
- mesenchymal stem cells
- endothelial cells
- tissue engineering
- hyaluronic acid
- bone marrow
- stem cells
- signaling pathway
- randomized controlled trial
- induced pluripotent stem cells
- obstructive sleep apnea
- clinical trial
- single molecule
- phase iii
- living cells
- finite element